Argos Therapeutics, Inc. reported earnings results for the third quarter and nine months ended September 30, 2017. For the quarter, the company reported revenue was $53,000 compared to $147,000 for the same period in 2016. For the nine months, the company reported revenue was $228,000 compared to $782,000 for the same period in 2016. Net loss for the nine months ended September 30, 2017 was $38.7 million compared to a net loss of $37.7 million for the same period in 2016.